MaxCyte, Inc. Holding(s) in Company (6159T)
March 30 2016 - 1:00PM
UK Regulatory
TIDMMXCT
RNS Number : 6159T
MaxCyte, Inc.
30 March 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
-------------------------------------------------------------------------------------
1. Identity of the issuer or MaxCyte, Inc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
--------------------------------------------------------- --------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
-------------------------------------------------------------------------------------
An acquisition or disposal of voting rights Yes
---------------------------------------------------------- -------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
---------------------------------------------------------- -------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
---------------------------------------------------------- -------------------------
An event changing the breakdown of voting rights
---------------------------------------------------------- -------------------------
Other (please
specify):
-------------------------------------------------------- -------------------------
3. Full name of person(s) Unicorn Asset Management
subject to the
notification obligation:
(iii)
--------------------------------------------------------- --------------------------
4. Full name of shareholder(s) Unicorn AIM VCT plc
(if different from 3.):(iv)
--------------------------------------------------------- --------------------------
5. Date of the transaction 29 March 2016
and date on
which the threshold is
crossed or
reached: (v)
--------------------------------------------------------- --------------------------
6. Date on which issuer 30 March 2016
notified:
--------------------------------------------------------- --------------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) 4%
--------------------------------------------------------- --------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- ---------------------------------- -------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
------------- ---------------- ---------------- -------------- ------------------------ -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- ------------ ------------ -------------- --------- ------------- ------------ -----------
UK57777K1060 0 2,142,857 4.93
------------- ---------------- ---------------- -------------- --------- ------------- ------------ -----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
----------------- -------------- -------------------------------- -------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
--------------- -------------- -------------- ---------------- -------------------------- -----------------------
Nominal Delta
--------------- -------------- -------------- ---------------- -------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
--------------------------------------------------- -----------------------------------------------------------------
2,142,857 4.93
--------------------------------------------------- -----------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
--------------------------------------------------------------------------------------------
Proxy Voting:
--------------------------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- -----------------------------
11. Number of voting rights proxy
holder will cease to hold:
------------------------------------------------------------- -----------------------------
12. Date on which proxy holder will
cease to hold voting rights:
------------------------------------------------------------- -----------------------------
13. Additional information: This disclosure has been
calculated based on there
being 43,470,461,shares in
issue
------------------------------------------------------------- -----------------------------
14. Contact name: Philip John
------------------------------------------------------------- -----------------------------
15. Contact telephone number: 020 7253 0889
------------------------------------------------------------- -----------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLLLFERVAIIVIR
(END) Dow Jones Newswires
March 30, 2016 13:00 ET (17:00 GMT)
Maxcyte (LSE:MXCT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Maxcyte (LSE:MXCT)
Historical Stock Chart
From Jul 2023 to Jul 2024
